1 – 8 of 8
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders
(
- Contribution to journal › Scientific review
- 2022
-
Mark
The Bárány Society position on 'Cervical Dizziness'
(
- Contribution to journal › Article
- 2019
-
Mark
Discovery of CGRP in relation to migraine
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Dr James Lance, Professor of Neurology in Sydney, Australia, died on 20 February 2019, age 92
(
- Contribution to journal › Article
- 2014
-
Mark
Pituitary adenylate cyclase activating polypeptide and migraine.
(
- Contribution to journal › Article
-
Mark
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.
(
- Contribution to journal › Article
- 2010
-
Mark
Measurement of vasoactive neuropeptides in biological materials: Problems and pitfalls from 30 years of experience and novel future approaches
(
- Contribution to journal › Scientific review
-
Mark
CGRP and its receptors provide new insights into migraine pathophysiology
(
- Contribution to journal › Scientific review